Complications in Anesthesia Practice Questions

Q: A 35-year-old male developed a headache relieved by lying down two days after a surgical procedure. What is the definitive treatment for this condition?

Autologous blood patch. ### Explanation The clinical presentation of a headache that is postural in nature (relieved by lying down and worsened by sitting or standing) following a surgical procedure (likely involving spinal or epidural anesthesia) is classic for **Post-Dural Puncture Headache (PDPH)**. **1. Why "Autologous Blood Patch" is correct:** While conservative management is often tried first, the **Epidural Blood Patch (EBP)** is considered the **definitive (gold standard) treatment** for PDPH. It involves injecting 15–20 ml of the patient's own venous blood into the epidural space at or near the level of the previous dural puncture. The blood clots to "plug" the dural hole, preventing further leakage of Cerebrospinal Fluid (CSF) and restoring intracranial pressure. **2. Why other options are incorrect:** * **NSAIDs and Caffeine (Options A & D):** These are components of **conservative management**. Caffeine causes cerebral vasoconstriction, which provides symptomatic relief by counteracting the compensatory vasodilation caused by low CSF pressure. However, they do not fix the underlying dural hole and are not "definitive." * **Physiotherapy (Option B):** There is no clinical role for physiotherapy in the management of PDPH. **3. High-Yield Clinical Pearls for NEET-PG:** * **Pathophysiology:** CSF leak through a dural rent $\rightarrow$ low CSF pressure $\rightarrow$ traction on pain-sensitive intracranial structures (vessels and nerves). * **Risk Factors:** Use of large-bore cutting needles (e.g., Tuohy), female gender, pregnancy, and young age. * **Needle Types:** **Quincke** (cutting) has the highest risk; **Sprotte and Whitacre** (pencil-point/non-cutting) have the lowest risk. * **Timing:** Usually appears within 48–72 hours post-procedure. * **Associated Symptom:** Occasional involvement of the 6th Cranial Nerve (Abducens), leading to diplopia.

Q: Which of the following is NOT a risk factor for developing bronchospasm during anesthesia?

Old age. **Explanation:** Bronchospasm is a sudden constriction of the muscles in the walls of the bronchioles, often triggered by airway hyperreactivity. **Why "Old Age" is the correct answer:** While elderly patients often have comorbidities (like COPD), **age itself is not an independent risk factor** for bronchospasm. In fact, airway hyperreactivity is generally more common and severe in children and young adults (due to smaller airway caliber and higher incidence of reactive airway diseases like asthma). Therefore, being elderly does not inherently predispose a patient to acute bronchospasm during induction or maintenance of anesthesia. **Why the other options are incorrect:** * **Perioperative Respiratory Infection (A):** This is a major risk factor. Recent viral infections (within 2–4 weeks) increase airway sensitivity and mucus production, significantly raising the risk of bronchospasm. * **Endotracheal Intubation (B):** Mechanical stimulation of the larynx and trachea by an ETT is the most common trigger for bronchospasm in the perioperative period, especially during "light" planes of anesthesia. * **Presence of COPD (C):** Patients with COPD or Asthma have baseline airway inflammation and hyperresponsiveness, making them highly susceptible to bronchoconstriction when exposed to irritants like volatile anesthetics or secretions. **Clinical Pearls for NEET-PG:** * **Management:** The first step in managing intraoperative bronchospasm is to **deepen the plane of anesthesia** (using Volatile agents like Sevoflurane, which is a potent bronchodilator) and administer 100% Oxygen. * **Drug of Choice:** In acute, severe cases, inhaled or IV **Beta-2 agonists (Salbutamol)** are the mainstay. * **Avoid:** Thiopental and Morphine should be used with caution in high-risk patients as they can trigger histamine release, potentially worsening bronchospasm. Ketamine is the induction agent of choice due to its bronchodilatory properties.

Q: Which disease is known to be associated with malignant hyperthermia?

Denborough syndrome. **Explanation:** **Malignant Hyperthermia (MH)** is a pharmacogenetic hypermetabolic crisis of skeletal muscle triggered by volatile anesthetics (e.g., Halothane, Sevoflurane) and depolarizing muscle relaxants (Succinylcholine). It is primarily caused by a mutation in the **RYR1 gene** (ryanodine receptor), leading to massive calcium release from the sarcoplasmic reticulum. **Why Denborough Syndrome is correct:** **King-Denborough Syndrome (KDS)** is a rare congenital myopathy characterized by a specific triad: dysmorphic features (short stature, ptosis, cryptorchidism), skeletal abnormalities, and a **high susceptibility to Malignant Hyperthermia**. It is the classic syndrome associated with MH in medical literature and exams. Other strongly associated conditions include Central Core Disease and Multiminicore Disease. **Analysis of Incorrect Options:** * **Huntington Chorea:** A neurodegenerative disorder involving the basal ganglia. While it involves motor symptoms, it has no known association with the RYR1 mutation or MH. * **Fabry Disease:** A lysosomal storage disorder (alpha-galactosidase A deficiency) affecting the kidneys and heart; it does not involve skeletal muscle calcium signaling. * **Burns:** While burn patients can develop **hyperkalemia** if given Succinylcholine (due to up-regulation of extrajunctional acetylcholine receptors), they do not have an increased genetic predisposition to MH itself. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Sign:** Increase in **EtCO₂** (End-tidal Carbon Dioxide) despite increasing ventilation. * **Most Specific Sign:** Muscle rigidity (especially Masseter Spasm). * **Drug of Choice:** **Dantrolene** (Mechanism: Acts on RYR1 to prevent calcium release). * **Safe Agents:** Propofol, Etomidate, Thiopentone, Ketamine, and all Non-depolarizing Neuromuscular Blockers (e.g., Vecuronium). * **Gold Standard Test:** Caffeine Halothane Contracture Test (CHCT).

Q: The caffeine-halothane test is used to diagnose which of the following conditions?

Malignant hyperthermia. **Explanation:** **Malignant Hyperthermia (MH)** is a pharmacogenetic hypermetabolic disorder of skeletal muscle triggered by volatile anesthetics (e.g., Halothane) and depolarizing muscle relaxants (Succinylcholine). The **Caffeine-Halothane Contracture Test (CHCT)** is the **gold standard (definitive) diagnostic test** for MH. It involves a muscle biopsy (usually from the vastus lateralis) where muscle strips are exposed to caffeine and halothane. In MH-susceptible individuals, the muscle fibers exhibit an exaggerated contractile response at lower concentrations compared to normal muscle due to a defect in the Ryanodine receptor (RYR1). **Analysis of Incorrect Options:** * **B. Neuroleptic Malignant Syndrome (NMS):** While clinically similar to MH (hyperthermia, rigidity), NMS is caused by dopamine antagonists (antipsychotics) and is not triggered by anesthetic gases. It does not show a positive CHCT. * **C. Thyrotoxicosis:** This is a hypermetabolic state due to excess thyroid hormone. While it can cause intraoperative tachycardia and hyperthermia, the underlying mechanism is hormonal, not a primary skeletal muscle calcium defect. * **D. King-Denborough Syndrome:** This is a rare congenital myopathy associated with MH susceptibility. While these patients are at high risk for MH, the CHCT is specifically used to diagnose the *susceptibility to Malignant Hyperthermia* itself, rather than the syndrome's dysmorphic features. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Sign of MH:** Increase in EtCO₂ (End-tidal Carbon Dioxide). * **Most Specific Sign:** Muscle rigidity (Masseter spasm). * **Drug of Choice:** **Dantrolene** (Mechanism: Inhibits calcium release from the sarcoplasmic reticulum by acting on RYR1). * **Genetic Mutation:** Most commonly involves the **RYR1 gene** on Chromosome 19. * **Safe Agents:** Propofol, Ketamine, Etomidate, and Nitrous Oxide.

Q: Muscle rigidity due to opioids is because of their effect on which receptor?

mu. **Explanation:** Opioid-induced muscle rigidity (often termed "stiff person syndrome" or "wooden chest syndrome") is a well-known side effect associated with high-dose, rapid intravenous administration of potent synthetic opioids like **Fentanyl, Sufentanil, and Remifentanil**. **Why Mu (μ) is correct:** The primary mechanism involves the activation of **mu-opioid receptors** located in the **striatum and the substantia nigra** (central nervous system). This activation leads to a decrease in GABAergic inhibition and an increase in dopaminergic activity, ultimately stimulating the spinal motor neurons. This results in intense rigidity of the thoracic and abdominal muscles, which can severely impede bag-mask ventilation and intubation. **Why other options are incorrect:** * **Kappa (κ):** These receptors are primarily associated with spinal analgesia, sedation, and miosis. They are also linked to dysphoria and psychotomimetic effects, but not muscle rigidity. * **Sigma (σ):** Formerly classified as opioid receptors, they are now considered non-opioid binding sites. They are associated with hallucinations and dysphoria (e.g., with Ketamine). * **Delta (δ):** These receptors play a role in spinal/supraspinal analgesia and modulating mu-receptor activity, but they do not mediate the motor-rigidity pathway. **High-Yield Clinical Pearls for NEET-PG:** 1. **Management:** The definitive treatment for opioid-induced rigidity is the administration of a **neuromuscular blocking agent** (e.g., Succinylcholine) and controlled ventilation. Naloxone can reverse it but will also abolish analgesia. 2. **Clinical Impact:** The most dangerous aspect is "Wooden Chest Syndrome," where chest wall compliance decreases so drastically that ventilation becomes impossible. 3. **Prevention:** Rigidity can be minimized by slow drug infusion and pre-treatment with a small dose of non-depolarizing muscle relaxants.

Q: Which of the following are postulated mechanisms by which propofol acts as an antiemetic?

All of the above. Propofol is unique among intravenous induction agents for its potent **antiemetic properties**, making it the drug of choice for Total Intravenous Anesthesia (TIVA) to prevent Postoperative Nausea and Vomiting (PONV). Its mechanism of action as an antiemetic is **multifactorial**, involving both central and peripheral pathways. ### **Mechanism of Action:** 1. **Antidopaminergic Activity:** Propofol exerts a weak antagonistic effect on **D2 receptors**. By inhibiting dopamine signaling, it reduces the stimulation of the emetic center. 2. **Depressant Effect on the CTZ:** It directly depresses the **Chemoreceptor Trigger Zone (CTZ)** in the area postrema and the subcortical centers, raising the threshold for vomiting. 3. **Neurotransmitter Modulation:** Propofol decreases the release of excitatory neurotransmitters like **Glutamate and Substance P** in the olfactory cortex. Furthermore, it reduces **serotonin (5-HT3)** levels in the area postrema, mimicking the action of specialized antiemetics like ondansetron. ### **Why "All of the Above" is Correct:** Since propofol utilizes all three pathways—dopamine antagonism, CTZ depression, and modulation of glutamate/serotonin—to suppress the vomiting reflex, option D is the most comprehensive and accurate answer. ### **High-Yield NEET-PG Pearls:** * **Sub-hypnotic Doses:** The antiemetic effect occurs at doses much lower than those required for induction (e.g., **10–20 mg IV** or a low-dose infusion of 10 µg/kg/min). * **PONV Gold Standard:** TIVA with Propofol is considered the most effective anesthetic strategy to reduce the baseline risk of PONV. * **PRIS:** Beware of **Propofol Related Infusion Syndrome** (metabolic acidosis, rhabdomyolysis, hyperkalemia) during prolonged high-dose infusions.

Q: What are the CNS affections of a local anesthetic agent?

All of the above. **Explanation:** Local Anesthetic (LA) systemic toxicity (LAST) primarily affects the Central Nervous System (CNS) and the Cardiovascular system. CNS symptoms typically precede cardiovascular collapse because the brain is highly sensitive to sodium channel blockade. The progression of CNS toxicity follows a predictable pattern based on increasing plasma concentrations: 1. **Initial/Early Signs (Option B):** At low toxic levels, patients experience sensory changes such as **perioral numbness**, tingling of the tongue, a metallic taste, and tinnitus. This occurs due to the high vascularity of these areas and the sensitivity of cranial nerves. 2. **Excitatory Phase (Option A):** As levels rise, LAs selectively inhibit cortical inhibitory pathways (GABAergic neurons) while leaving excitatory pathways unopposed. This leads to agitation, muscle twitching, and eventually **grand mal convulsions**. 3. **Depressive Phase (Option C):** At very high concentrations, both inhibitory and excitatory pathways are inhibited, leading to generalized **CNS depression**. This manifests as unconsciousness, respiratory depression, and eventually coma. Since all three options represent different stages of the clinical spectrum of CNS toxicity, **Option D (All of the above)** is the correct answer. **High-Yield NEET-PG Pearls:** * **Potency vs. Toxicity:** Bupivacaine is more cardiotoxic than Lidocaine. The "CC/CNS ratio" (dose required for cardiovascular collapse vs. dose for convulsions) is lower for Bupivacaine, making it more dangerous. * **First Sign:** Perioral numbness/metallic taste is often the earliest warning sign of accidental intravascular injection. * **Management:** The specific antidote for LAST is **20% Intralipid (Lipid Emulsion Therapy)**. * **Hypercapnia/Acidosis:** Increases the risk of CNS toxicity by increasing cerebral blood flow (delivering more drug to the brain) and decreasing the seizure threshold.

Question 1

A 35-year-old male developed a headache relieved by lying down two days after a surgical procedure. What is the definitive treatment for this condition?

Accepted Answer

Autologous blood patch

Answer

NSAIDs and caffeine

Answer

Physiotherapy

Answer

Caffeine

Question 2

Which of the following is NOT a risk factor for developing bronchospasm during anesthesia?

Accepted Answer

Old age

Answer

Perioperative respiratory infection

Answer

Endotracheal intubation

Answer

Presence of COPD

Question 3

Which disease is known to be associated with malignant hyperthermia?

Accepted Answer

Denborough syndrome

Answer

Huntington chorea

Answer

Fabry disease

Answer

Burns

Question 4

What is responsible for muscle pain after day care surgery when propofol and succinylcholine (Sch) are used?

Accepted Answer

Succinylcholine (Sch)

Answer

Propofol

Answer

Surgery

Answer

Early ambulation

Question 5

The caffeine-halothane test is used to diagnose which of the following conditions?

Accepted Answer

Malignant hyperthermia

Answer

Neuroleptic malignant syndrome

Answer

Thyrotoxicosis

Answer

King-Denborough syndrome

Question 6

Abnormal plasma choline esterase produces apnea due to which of the following?

Accepted Answer

Suxamethonium

Answer

Halothane

Answer

Lignocaine

Answer

Isoflurane

Question 7

Administration of succinylcholine produces dangerous hyperkalemia in which of the following conditions?

Accepted Answer

Paraplegia

Answer

Fracture of femur

Answer

Conditions causing elevated intracranial pressure

Answer

Acute renal failure

Question 8

Muscle rigidity due to opioids is because of their effect on which receptor?

Accepted Answer

mu

Answer

kappa

Answer

sigma

Answer

delta

Question 9

Which of the following are postulated mechanisms by which propofol acts as an antiemetic?

Accepted Answer

All of the above

Answer

Antidopaminergic activity

Answer

Depressant effect on the chemoreceptor trigger zone

Answer

Decreased release of glutamate and substance P in the olfactory cortex and decreased serotonin

Question 10

What are the CNS affections of a local anesthetic agent?

Accepted Answer

All of the above

Answer

Convulsion

Answer

Perioral numbness

Answer

Depression

Complications in Anesthesia — MCQs

Complications in Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?